The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Development of a New Vaccine for the Prevention of Lassa Fever
Open accessAbstract
BACKGROUND: Recent importation of Lassa fever into Germany, the Netherlands, the United Kingdom, and the United States by travelers on commercial airlines from Africa underscores the public health challenge of emerging viruses. Currently, there are no licensed vaccines for Lassa fever, and no experimental vaccine has completely protected nonhuman primates against a lethal challenge. METHODS AND FINDINGS: We developed a replication-competent vaccine against Lassa virus based on attenuated recombinant vesicular stomatitis virus vectors expressing the Lassa viral glycoprotein. A single intramuscular vaccination of the Lassa vaccine elicited a protective immune response in nonhuman primates against a lethal Lassa virus challenge. Vaccine shedding was not detected in the monkeys, and none of the animals developed fever or other symptoms of illness associated with vaccination. The Lassa vaccine induced strong humoral and cellular immune responses in the four vaccinated and challenged monkeys. Despite a transient Lassa viremia in vaccinated animals 7 d after challenge, the vaccinated animals showed no evidence of clinical disease. In contrast, the two control animals developed severe symptoms including rashes, facial edema, and elevated liver enzymes, and ultimately succumbed to the Lassa infection. CONCLUSION: Our data suggest that the Lassa vaccine candidate based on recombinant vesicular stomatitis virus is safe and highly efficacious in a relevant animal model that faithfully reproduces human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
McCormick, J. B., King, I. J., Webb, P. A., Scribner, C. L., Craven, R. B., Johnson, K. M., Elliott, L. H., & Belmont-Williams, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601023140104 · Cited by 999
Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management
Borio, L., Inglesby, T., Peters, C. J., Schmaljohn, A. L., Hughes, J. M., Jahrling, P. B., Ksiazek, T., Johnson, K. M., Meyerhoff, A., O'Toole, T., et al. (2002) · JAMA · doi:10.1001/jama.287.18.2391 · Cited by 672
Self-citationDevelopment of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
A Prospective Study of the Epidemiology and Ecology of Lassa Fever
McCormick, J. B., Webb, P. A., Krebs, J. W., Johnson, K. M., & Smith, E. S. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.3.437 · Cited by 622
Manual of Clinical Microbiology
Kepler, J. A. (1975) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/32.4.438 · Cited by 497
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Xu, L., Yang, Z.-Y., Roederer, M., Koup, R. A., Jahrling, P. B., & Nabel, G. J. (2003) · Nature · doi:10.1038/nature01876 · Cited by 462
Self-citationAn Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants
Rose, N. F., Marx, P. A., Luckay, A., Nixon, D. F., Moretto, W. J., Donahoe, S. M., Montefiori, D., Roberts, A., Buonocore, L., & Rose, J. K. (2001) · Cell · doi:10.1016/s0092-8674(01)00482-2 · Cited by 440
Garbutt, M., Liebscher, R., Wahl-Jensen, V., Jones, S., Möller, P., Wagner, R., Volchkov, V., Klenk, H.-D., Feldmann, H., & Ströher, U. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5458-5465.2004 · Cited by 381
Self-citationReview of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice
Fisher-Hoch, S. P., Tomori, O., Nasidi, A., Perez-Oronoz, G. I., Fakile, Y., Hutwagner, L., & McCormick, J. B. (1995) · BMJ · doi:10.1136/bmj.311.7009.857 · Cited by 370
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P
Lenz, O., ter Meulen, J., Klenk, H.-D., Seidah, N. G., & Garten, W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221447598 · Cited by 345
Attenuated Vesicular Stomatitis Viruses as Vaccine Vectors
Roberts, A., Buonocore, L., Price, R., Forman, J., & Rose, J. K. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3723-3732.1999 · Cited by 280
Schnell, M. J., Buonocore, L., Kretzschmar, E., Johnson, E., & Rose, J. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11359 · Cited by 274
Lassa Virus Z Protein Is a Matrix Protein Sufficient for the Release of Virus-Like Particles
Strecker, T., Eichler, R., Meulen, J. T., Weissenhorn, W., Dieter Klenk, H., Garten, W., & Lenz, O. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10700-10705.2003 · Cited by 251
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
Geisbert, T. W., Pushko, P., Anderson, K., Smith, J., Davis, K. J., & Jahrling, P. B. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0805.010284 · Cited by 248
Self-citationRoberts, A., Kretzschmar, E., Perkins, A. S., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4704-4711.1998 · Cited by 228
Gallaher, W. R., DiSimone, C., & Buchmeier, M. J. (2001) · BMC Microbiology · doi:10.1186/1471-2180-1-1 · Cited by 169
Imported Lassa Fever in Germany: Surveillance and Management of Contact Persons
Haas, W. H., Breuer, T., Pfaff, G., Schmitz, H., Kohler, P., Asper, M., Emmerich, P., Drosten, C., Golnitz, U., Fleischer, K., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374853 · Cited by 167
Monitoring of clinical and laboratory data in two cases of imported Lassa fever
SCHMITZ, H. E., Köhler, B., Laue, T., Drosten, C., Veldkamp, P. J., Günther, S., Emmerich, P., Geisen, H. P., Fleischer, K., Beersma, M. F. C., et al. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(01)01508-8 · Cited by 128
Piedra, P. A., Poveda, G. A., Ramsey, B. W., McCoy, K., & Hiatt, P. (1998) · PEDIATRICS · doi:10.1542/peds.101.6.1013 · Cited by 115
Fisher‐Hoch, S. P., & McCormick, J. B. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.2.189 · Cited by 82
Imported Lassa Fever: New Jersey, 2004
(2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154219.12612.06 · Cited by 39
On the Front Lines of Lassa Fever
Bausch, D. G., Sesay, S., & Oshin, B. (2004) · Emerging infectious diseases · doi:10.3201/eid1010.im1010 · Cited by 23
Lassa fever imported to England
Jones, J. P. (2000) · Weekly releases (1997–2007) · doi:10.2807/esw.04.11.01639-en · Cited by 20
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Rodent-borne diseases and their risks for public health
Meerburg, B. G., Singleton, G. R., & Kijlstra, A. (2009) · Critical Reviews in Microbiology · doi:10.1080/10408410902989837 · Cited by 1,003
Case, J. B., Rothlauf, P. W., Chen, R. E., Liu, Z., Zhao, H., Kim, A. S., Bloyet, L.-M., Zeng, Q., Tahan, S., Droit, L., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.021 · Cited by 410
Effective Post-Exposure Treatment of Ebola Infection
Feldmann, H., Jones, S. M., Daddario-DiCaprio, K. M., Geisbert, J. B., Ströher, U., Grolla, A., Bray, M., Fritz, E. A., Fernando, L., Feldmann, F., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030002 · Cited by 288
Self-citationGeisbert, T. W., Geisbert, J. B., Leung, A., Daddario-DiCaprio, K. M., Hensley, L. E., Grolla, A., & Feldmann, H. (2009) · Journal of Virology · doi:10.1128/jvi.00561-09 · Cited by 275
Self-citation
Metadata
- Authors
- Geisbert, T. W., Jones, S., Fritz, E. A., Shurtleff, A. C., Geisbert, J. B., Liebscher, R., Grolla, A., Ströher, U., Fernando, L., Daddario, K. M., Guttieri, M. C., Mothé, B. R., Larsen, T., Hensley, L. E., Jahrling, P. B., & Feldmann, H.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2005-06-28
- Volume
- 2
- Issue
- 6
- Pages
- e183
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2124577002
- Cited by
- 279
- References
- 25
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.